Additional file 1: of Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores

Abstract

Table S1. Chemotherapy receipt by age group, with age separated into three tiers using 35 and 50 years as clinically relevant thresholds. Chemotherapy receipt was significantly dependent on age group in this study (chi-square test, p < 0.001). (DOCX 15 kb